HBW-008-A, a Novel, Potent, Selective, Safe and Bioavailable p21-Activated Kinase 4 (PAK4) Inhibitor, is an Efficacious Adjuvant Agent for PD-1 Therapy in Mice
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2023
has subject area
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Pharmacology & Pharmacy (Science Metrix)